Literature DB >> 1705625

Biochemical characterization of two angiotensin II receptor subtypes in the rat.

M de Gasparo1, S Whitebread, M Mele, A S Motani, P J Whitcombe, H P Ramjoué, B Kamber.   

Abstract

Two angiotensin II receptor subtypes, A and B, have been described by means of specific and selective ligands (Biochem Biophys Res Commun 1989; 163:284-91). The present report describes the binding characteristics and the distribution of these subtypes in various rat tissues. Adrenal and uterus expressed both subtypes but in different proportions. Subtype B predominated in the adrenal glomerulosa (60%), whereas there was a greater proportion of subtype A in the medulla (70%). In uterus, subtype B was preferentially expressed (70%), and there was no difference in receptor distribution between muscle layers and serosa. Liver, kidney, and cultured aortic smooth muscle cells expressed only subtype B. In all of the tissues tested, the Ki values of various competing ligands were similar for each subtype expressed. It is proposed that subtype B is the vascular receptor. The function of subtype A, however, is still to be determined.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1705625     DOI: 10.1097/00005344-199016004-00008

Source DB:  PubMed          Journal:  J Cardiovasc Pharmacol        ISSN: 0160-2446            Impact factor:   3.105


  10 in total

1.  Effect of luminal angiotensin II receptor antagonists on proximal tubule transport.

Authors:  A Quan; M Baum
Journal:  Am J Hypertens       Date:  1999-05       Impact factor: 2.689

2.  The role of the renin-angiotensin system in the renal response to moderate hypoxia in the rat.

Authors:  M Neylon; J Marshall; E J Johns
Journal:  J Physiol       Date:  1996-03-01       Impact factor: 5.182

3.  Pharmacological characterization of angiotensin-induced depolarizations of rat superior cervical ganglion in vitro.

Authors:  A B Hawcock; J C Barnes; A D Michel
Journal:  Br J Pharmacol       Date:  1992-03       Impact factor: 8.739

4.  Development of polyclonal antibodies against angiotensin type 2 receptors.

Authors:  L P Reagan; M Theveniau; X D Yang; I R Siemens; D K Yee; T Reisine; S J Fluharty
Journal:  Proc Natl Acad Sci U S A       Date:  1993-09-01       Impact factor: 11.205

5.  Human AT1 receptor is a single copy gene: characterization in a stable cell line.

Authors:  N Aiyar; E Baker; H L Wu; P Nambi; R M Edwards; J J Trill; C Ellis; D J Bergsma
Journal:  Mol Cell Biochem       Date:  1994-02-09       Impact factor: 3.396

6.  Pharmacological profile of GR117289 in vitro: a novel, potent and specific non-peptide angiotensin AT1 receptor antagonist.

Authors:  M J Robertson; J C Barnes; G M Drew; K L Clark; F H Marshall; A Michel; D Middlemiss; B C Ross; D Scopes; M D Dowle
Journal:  Br J Pharmacol       Date:  1992-12       Impact factor: 8.739

7.  Angiotensin II contractions in coronary artery. Nature of receptors and calcium pools.

Authors:  A K Grover; V P Fomin; S E Samson
Journal:  Mol Cell Biochem       Date:  1994-06-15       Impact factor: 3.396

8.  The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells.

Authors:  M Stoll; U M Steckelings; M Paul; S P Bottari; R Metzger; T Unger
Journal:  J Clin Invest       Date:  1995-02       Impact factor: 14.808

9.  Angiotensin II receptor blockade with single doses of valsartan in healthy, normotensive subjects.

Authors:  P Müller; T Cohen; M de Gasparo; A Sioufi; A Racine-Poon; H Howald
Journal:  Eur J Clin Pharmacol       Date:  1994       Impact factor: 2.953

Review 10.  Malaria and hypertension. Another co-evolutionary adaptation?

Authors:  Julio Gallego-Delgado; Ana Rodriguez
Journal:  Front Cell Infect Microbiol       Date:  2014-09-03       Impact factor: 5.293

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.